Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy

Expression of androgen receptor (AR) splice variant 7 (AR-V7) has been identified as the mechanism associated with the development of castration-resistant prostate cancer (CRPC). However, a potential link between AR-V7 expression and resistance to taxanes, such as docetaxel or cabazitaxel, has not b...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Yasuomi, Tamada, Satoshi, Kato, Minoru, Hirayama, Yukiyoshi, Takeyama, Yuji, Iguchi, Taro, Sadar, Marianne D., Nakatani, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262607/
https://www.ncbi.nlm.nih.gov/pubmed/30453546
http://dx.doi.org/10.3390/jcm7110444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262607/
https://www.ncbi.nlm.nih.gov/pubmed/30453546
http://dx.doi.org/10.3390/jcm7110444

Ejemplares similares